Transcat, Inc. (NASDAQ:TRNS) VP Robert A. Flack purchased 1,100 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were purchased at an average cost of $12.30 per share, for a total transaction of $13,530.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Transcat, Inc. (TRNS) traded down $0.28 on Thursday, hitting $12.28. The stock had a trading volume of 1,907 shares, compared to its average volume of 38,194. Transcat, Inc. has a fifty-two week low of $10.15 and a fifty-two week high of $15.15. The company has a quick ratio of 1.68, a current ratio of 2.24 and a debt-to-equity ratio of 0.61. The company has a market cap of $89.63, a P/E ratio of 20.57, a price-to-earnings-growth ratio of 3.02 and a beta of 0.38.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://theolympiareport.com/2017/11/09/insider-buying-transcat-inc-trns-vp-acquires-13530-00-in-stock.html.

Institutional investors and hedge funds have recently bought and sold shares of the company. Northern Trust Corp grew its position in shares of Transcat by 9.5% during the 2nd quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock worth $220,000 after buying an additional 1,570 shares in the last quarter. QCI Asset Management Inc. NY grew its position in shares of Transcat by 10.0% during the 2nd quarter. QCI Asset Management Inc. NY now owns 24,587 shares of the scientific and technical instruments company’s stock worth $299,000 after buying an additional 2,226 shares in the last quarter. Quantum Capital Management bought a new position in shares of Transcat during the 3rd quarter worth $696,000. Vanguard Group Inc. grew its position in shares of Transcat by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock worth $1,623,000 after buying an additional 4,450 shares in the last quarter. Finally, Neuberger Berman Group LLC grew its position in shares of Transcat by 3.1% during the 2nd quarter. Neuberger Berman Group LLC now owns 164,993 shares of the scientific and technical instruments company’s stock worth $2,005,000 after buying an additional 4,900 shares in the last quarter. 56.06% of the stock is currently owned by institutional investors and hedge funds.

Separately, Dougherty & Co initiated coverage on Transcat in a research report on Wednesday, August 23rd. They set a “buy” rating and a $20.00 price target on the stock.

About Transcat

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Insider Buying and Selling by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.